Notably, we further identified multiple reported malignancy‐related genes (e.g., MET, PIK3R1, PRKCA, PTEN, SHC1, and STAT3) upregulated in HCC272, and demonstrated that these genes were mainly enriched for cancer‐related functions, which were associated with broad drug resistance. The gene discussed is MET; the disease is cancer.